Epigenetic inactivation of the splicing RNA-binding protein CELF2 in human breast cancer-Reference-Cited by-同舟云学术

Epigenetic inactivation of the splicing RNA-binding protein CELF2 in human breast cancer

Published:2019-08-13 Issue:45 Volume:38 Page:7106-7112
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Piqué Laia,Martinez de Paz Alexia,Piñeyro David,Martínez-Cardús Anna^ORCID,Castro de Moura Manuel,Llinàs-Arias Pere,Setien Fernando,Gomez-Miragaya Jorge^ORCID,Gonzalez-Suarez Eva,Sigurdsson Stefan^ORCID,Jonasson Jon G.,Villanueva Alberto^ORCID,Vidal August,Davalos Veronica,Esteller Manel

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/s41388-019-0936-x.pdf

Reference24 articles.

1. Nilsen TW, Graveley BR. Expansion of the eukaryotic proteome by alternative splicing. Nature. 2010;463:457–63.

2. Kalsotra A, Cooper TA. Functional consequences of developmentally regulated alternative splicing. Nat Rev Genet. 2011;12:715–29.

3. Pan Q, Shai O, Lee LJ, Frey BJ, Blencowe BJ. Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat Genet. 2008;40:1413–5.

4. Papasaikas P, Valcárcel J. The Spliceosome: the ultimate RNA chaperone and sculptor. Trends Biochem Sci. 2016;41:33–45.

5. Dvinge H, Bradley RK. Widespread intron retention diversifies most cancer transcriptomes. Genome Med. 2015;7:45.

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effects of NLRP3 rs10754558 and rs4612666 polymorphisms on preeclampsia susceptibility, onset, and severity: a case-control study and in silico analysis;MOL BIOL RES COMMUN;2024

2. Loss of CELF2 promotes skin tumorigenesis and increases drug resistance;International Journal of Dermatology;2024-06-17

3. Loss of RNA-binding protein CELF2 promotes acute leukemia development via FAT10-mTORC1;Oncogene;2024-03-21

4. RNA-binding proteins in breast cancer: Biological implications and therapeutic opportunities;Critical Reviews in Oncology/Hematology;2024-03

5. Tumor-wide RNA splicing aberrations generate immunogenic public neoantigens;2023-10-20